Coya Therapeutics, Inc. (COYA)
Nasdaq: COYA · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2021
Who owns Coya Therapeutics, Inc.
As filed with the SECHolders of 5% or more
2
DME Advisors GP, L.L.C. holds 9.9% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Feb 14, 2025 says.
Directors and officers
10
report now, of 12 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
DME Advisors GP, L.L.C.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.0001 per share
Dr. Reddy's Laboratories, Inc.
SCHEDULE 13G · filed Mar 12, 2026 · Common Stock, $0.0001 par value per share
The Vanguard Group
SCHEDULE 13G/A · filed Jan 30, 2026 · Common Stock · reported falling below 5%
Orin Hirschman
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.3% in Jan 28, 2026
What COYA reports owning in othersstakes of 5% or more, and other ties
Coya Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.